Publication | Open Access
Heterogeneity of Phosphatidylinositol-3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin Activation in Cancer: Is PI3K Isoform Specificity Important?
17
Citations
17
References
2018
Year
/Akt/mammalian TargetCancer Molecular TargetsPathologyRapamycin ActivationTumor BiologyTherapeutics Volume 7OncologySignaling PathwayReceptor Tyrosine KinaseCancer Cell BiologyRadiation OncologyCell SignalingMolecular OncologyCancer ResearchOpinion Article FrontCancer TreatmentMalignant DiseaseCell BiologyTumor MicroenvironmentSignal TransductionImmune Checkpoint InhibitorTumor SuppressorMedicine
OPINION article Front. Oncol., 22 January 2018Sec. Cancer Molecular Targets and Therapeutics Volume 7 - 2017 | https://doi.org/10.3389/fonc.2017.00330
| Year | Citations | |
|---|---|---|
Page 1
Page 1